Small Soteria-inspired unit vs. standard closed ward for acute psychosis
Official title: Psychiatric Hospitalization in a Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward: A Randomized Controlled Trial
Run by Jerusalem Mental Health Center · NCT07836348 · Data updated 2026-11-12
A randomized or semi-randomized comparison tests whether a small Soteria-style inpatient unit improves outcomes for adults with acute psychosis compared to a conventional closed psychiatric ward.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 200 (estimated) |
| Sponsor | Jerusalem Mental Health Center Government |
| Locations | 1 site (Jerusalem, Jerusalem) |
| Status | Recruiting |
| Started | September 25, 2025 |
| Main results expected | May 1, 2028 |
| Study ends | June 1, 2029 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT07836348 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult males 18 years or older experiencing an acute psychotic episode requiring admission to a closed inpatient unit and meeting defined PANSS-6 criteria.
✕Probably not a fit
Patients with primary substance-related hospitalization, complex organic conditions, or recent long hospitalizations may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares two inpatient care approaches for adults with moderate-to-severe acute psychosis admitted to a closed unit. Eligible participants are randomly assigned to a small unit that uses Soteria elements or to the standard closed ward, with allocation concealed at baseline when possible. Real-world constraints may affect randomization, including bed availability and consent timing. The study includes follow-up at one year, with compensation for in-person follow-up visits to support retention. Primary emphasis is on stabilizing acute symptoms and evaluating longer-term outcomes in a real clinical setting in Jerusalem.
Why it matters
Potential benefit: If successful, the Soteria-inspired unit could offer a more person-centered approach that helps reduce distress and improve outcomes during and after hospitalization.
How similar studies have gone: Prior work in similar settings suggests potential benefits of alternative, less conventional inpatient care models, but this specific Soteria-inspired approach in a closed unit is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male participants aged 18 years or older. * Acute psychiatric condition requiring admission to a closed psychiatric inpatient setting. * Moderate-to-severe psychotic symptoms, defined as a six-item Positive and Negative Syndrome Scale (PANSS-6) total score greater than 14 and at least one PANSS-6 item rated 5 or higher. * Admission directly from the psychiatric emergency department. * Stay of at least 5 days in the assigned study inpatient setting. * Provision of informed consent to participate in the study. * Voluntary or involuntary legal admission status. Exclusion Criteria: * Previous psychiatric hospitalization ending less than one month before the current admission. * Hospitalization in the assigned study inpatient setting exceeding 180 days. * Substance use as the primary clinical problem requiring hospitalization. * Active organic medical condition requiring ongoing intensive medical monitoring. * Intellectual developmental disability. * Complex organic brain disorder, including dementia.
Where it's running
-
Jerusalem Mental Health Center
Jerusalem, Jerusalem, Israel Recruiting
Study contacts
- Principal investigator: Pesach Lichtenberg, MD — Jerusalem Mental Health Center
- Study coordinator: Avraham Friedlander, PhD
- Email: avremi13@gmail.com
- Phone: +972506801173
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.
-
Accelerated Brain Stimulation for Young People at Risk of Psychosis
This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.
-
Racial differences in how people experience paranoia
This project will see if brief race-related stressful experiences increase feelings of paranoia in Black American adults who take online surveys.
-
Yoga-based group program plus usual care for outpatients with schizophrenia spectrum disorders
This project will see if a 12-week yoga-based group program added to usual outpatient care helps adults with schizophrenia spectrum disorders reduce stress and symptom-related distress compared with exercise or usual care alone.
-
Trying the Kiso Mind smartphone app for people with schizophrenia spectrum disorders
This study tests whether the Kiso Mind smartphone app is acceptable, practical, and helpful for adults with schizophrenia or schizoaffective disorder alongside their usual care.
-
Multimodal physical exercise program for people with psychosis on long-acting injectable antipsychotics
This program will try a supervised, structured exercise course to see if it improves physical fitness, mental well‑being, and metabolic health in adults with psychosis who are on long‑acting injectable antipsychotics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.